PDE10A mutation in two sisters with a hyperkinetic movement disorder - Response to levodopa.
作者信息
Knopp C, Häusler M, Müller B, Damen R, Stoppe A, Mull M, Elbracht M, Kurth I, Begemann M
机构信息
Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.
出版信息
Parkinsonism Relat Disord. 2019 Jun;63:240-242. doi: 10.1016/j.parkreldis.2019.02.007. Epub 2019 Feb 10.
Abstract
摘要
相似文献
1
PDE10A mutation in two sisters with a hyperkinetic movement disorder - Response to levodopa.
Parkinsonism Relat Disord. 2019 Jun;63:240-242. doi: 10.1016/j.parkreldis.2019.02.007. Epub 2019 Feb 10.
2
Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies.
Parkinsonism Relat Disord. 2021 Jan;82:7-9. doi: 10.1016/j.parkreldis.2020.11.008. Epub 2020 Nov 14.
3
Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
J Neural Transm (Vienna). 2001;108(5):559-70. doi: 10.1007/s007020170056.
4
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Neurosci Res. 2010 Sep;68(1):44-50. doi: 10.1016/j.neures.2010.06.003. Epub 2010 Jun 11.
5
Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans.
Psychopharmacology (Berl). 2012 Jun;221(3):389-96. doi: 10.1007/s00213-011-2586-8. Epub 2011 Nov 26.
6
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
Eur J Pharmacol. 2010 Jun 10;635(1-3):109-16. doi: 10.1016/j.ejphar.2010.03.006. Epub 2010 Mar 19.
7
Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Clin Exp Pharmacol Physiol. 2014 Sep;41(9):685-90. doi: 10.1111/1440-1681.12270.
8
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Eur Neurol. 1987;27 Suppl 1:9-20. doi: 10.1159/000116170.
9
L-DOPA exacerbates amphetamine-induced dopamine depletion.
Mol Chem Neuropathol. 1998 Feb;33(2):81-97. doi: 10.1007/BF02870183.
10
Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys.
Eur J Pharmacol. 2001 Feb 2;412(3):247-54. doi: 10.1016/s0014-2999(01)00737-3.
引用本文的文献
1
Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke.
Mol Neurobiol. 2022 Jan;59(1):574-589. doi: 10.1007/s12035-021-02621-5. Epub 2021 Nov 4.
2
Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme.
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):677-688. doi: 10.1073/pnas.1916398117. Epub 2019 Dec 23.
Zotero 插件